$AUNA

Auna S.A. (AUNA) Cleared to Start Lima PPP Build

Auna S.A. (AUNA) has met all conditions to start building the Centro Ambulatorio Trecca under a PPP with EsSalud. Construction begins now, with operations expected to start in late 2028. The project has guaranteed minimum volumes.

Original reporting
Published Oct 21, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Auna S.A. (AUNA) Cleared to Start Lima PPP Build — source image
Decision brief

The 30-second read

$AUNABullishLow
01

Why it matters

The clearance moves the project into the investment phase, unlocking milestone payments and setting a timeline for revenue generation.

02

Market read

A first‑report milestone for a micro‑cap healthcare PPP; modest trading relevance.

03

What to watch

Financing terms of the PPP and eventual EBITDA once operations start are still uncertain.

Relevance 5/10Novelty 5/10Timing: today

Background

Auna S.A. operates a network of private hospitals and clinics in Latin America and uses PPP models to expand.

Company-level read

Ticker impact

$AUNABullishMedium confidence
Context

Auna S.A. received clearance to begin construction of the Centro Ambulatorio Trecca under its PPP with EsSalud.

Expected impact

modest upside as construction payments are priced in

Evidence & confidence

First report of construction start; investors will value upcoming cash flows but scale is limited.

Market effects

Highlights growth of PPP healthcare projects in Peru, may benefit regional construction and health service providers.

Positive signal for Peruvian infrastructure investors.

Limited, primarily a micro‑cap foreign story.

Counterpoint

Construction delays or cost overruns could pressure the stock despite the milestone.

Key entities

  • Auna S.A.

    Peruvian healthcare operator listed on NYSE under AUNA.

  • EsSalud

    Peruvian public health insurance entity partnering with Auna.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

$AUNAMed

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea